Description:
Kalorama Information presents a comprehensive analysis of the evolving global blood screening market in its latest report, World Market for Blood Screening, 2022. This multibillion-dollar market is crucial for ensuring the safety of the blood supply by detecting infectious diseases and conditions. The report provides insights into market dynamics, technological advancements, and regional developments, making it an essential resource for stakeholders in the blood screening industry.
Report Highlights:
- Market Overview:
- Blood screening is a critical medical process for detecting pathogens in donated blood, particularly in developed nations.
- The market, though mature, is experiencing growth driven by new technologies, increased testing volumes, and expansion in developing nations.
- Primary Objectives of Blood Screening Testing:
- Monitoring the emergence of new infectious agents in the blood supply.
- Determining causes of transfusion reactions with unknown etiology.
- Assessing the effectiveness of new donor screening methods.
- Evaluating and improving the blood donation process to ensure an adequate supply.
- Key Market Drivers:
- The aging population in developed markets.
- New test applications enhancing diagnostic capabilities.
- Significant growth potential in emerging markets as developing nations implement stricter blood safety measures, particularly through Nucleic Acid Testing (NAT).
For further details and to purchase directly, please contact us.
Sample Report: A sample is available as a PDF upon request.
Table: Global Blood Typing Sales Distribution, by Region, 2021 (%)
| Region | % Mkt |
| North America | XX% |
| Europe | XX% |
| Asia Pacific | XX% |
| RoW | XX% |
Source: Kalorama Information
